Boston Scientific Corp.

NYSE:BSX  
42.91
+0.07 (+0.16%)
Products

FDA Says Boston Scientific Recalls VICI VENOUS STENT System And VICI RDS VENOUS STENT System

Published: 05/21/2021 18:39 GMT
Boston Scientific Corp. (BSX) - :fda - Boston Scientific Corporation Recalls Vici Venous Stent System and Vici Rds Venous Stent System for Potential of Stent Migration.
FDA - Identified Recall of Boston Scientific's Vici Venous Stent System and Vici Rds Venous Stent System As a Class I Recall.